BPH relief, engineered differently.
Experience a treatment pathway for benign prostatic hyperplasia. No heat, no permanent implants—just structural precision designed for clinical safety and sexual health preservation.
The only BPH treatment worldwide with zero heat, zero resection, zero implant
Nexusuro is an international urology brand.
We focus on minimally invasive solutions for BPH treatment, connecting product pathways with channel partners and clinical delivery support worldwide.
See TUCBDP in Action
Precision Engineering in Action
Positioning Balloon
The positioning balloon secures the catheter in place, eliminating the need for DRE. After inflation, gently pull the catheter outward until seated against the bladder neck.
Anchoring Balloon
The anchoring balloon is inflated between the bladder neck and external urethral sphincter to anchor the catheter, minimizing slippage during dilation.
Dilating Balloon
The dilating balloon is precisely positioned between the two inner balloons, applying uniform force only to the targeted prostatic lesion area for precise dilation.
Rethinking BPH Treatment
Understanding the limitations of traditional therapies is the first step toward a more effective solution.
~50%
of men over age 50 are affected by symptomatic BPH.
50–75%
TURP retrograde ejaculation rate — a leading reason patients hesitate to pursue surgery.
40%+
of patients discontinue alpha-blocker therapy within the first year due to side effects or insufficient relief.
Understanding TUCBDP
Transurethral Columnar Balloon Dilation of the Prostate offers a precisely engineered alternative to ablation and permanent implants.
Non-Thermal
Unlike laser or steam treatments, TUCBDP uses no heat, protecting sensitive surrounding tissues and nerve bundles.
Non-Implant
Achieve results without leaving permanent foreign bodies in the anatomy, reducing long-term irritation and removal risks.
Structural Dilation
A mechanical approach that splits the prostate capsule symmetrically to create a wide, lasting urinary channel.
Choose Your Path
Retrograde ejaculation rate 4.45%. Gao et al. (N=265).
From 20.2 to 6.6. Huang 2016 (N=565), median follow-up >3 years.
Peak urinary flow rate from 8.91 to 18.11 mL/s. Zhou 2022 (N=2,050).
TUCBDP vs. 12.86% TURP (P=0.042). Zhang 2022 (N=140).
Ready to learn more?
Connect with our clinical specialists to explore how Nexusuro is setting a new standard for BPH care.